SGK1 and central nervous system disorder: Because the glial pathologies shown to be improved by SGK1 inhibition in this study commonly underlie other CNS disorders, SGK1 inhibition might eventually become a therapeutic intervention that is broadly applicable to a variety of neurodegenerative disorders and neurologic injuries.